Overview

Absolute Bioavailability and ADME Study of [14C]AZD9977 in Healthy Male Subjects

Status:
Completed
Trial end date:
2021-02-04
Target enrollment:
Participant gender:
Summary
Study to Assess the Absorption, Metabolism, and Excretion of [14C]AZD9977 after a Single-Dose Oral Administration
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Collaborator:
Quotient Sciences